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Background: Slow coronary ﬂow (SCF) is deﬁned as delayed opaciﬁcation of
coronary arteries during coronary angiography without signiﬁcant stenosis and is
associated with myocardial perfusion abnormalities, myocardial ischemia and
myocardial infarction. Although the certain etiology and pathophysiologic mechanism
of SCF patients is still unknown, possible underlying mechanisms are endotelial
dysfunction, chronic inﬂammation, microvascular dysfunction and diffuse
atherosclerosis.
Lectin-like oxidized low density lipoprotein (LDL) receptor-1 (LOX-1); a receptor
for oxidized-LDL; seems to play important roles in the pathogenesis of atherosclerotic
plaque development and progression. LOX-1 is released as soluble forms (sLOX-1)
after proteolytic cleavage that can be measured in serum.
The association between sLOX-1 and multiple stages of vascular dysfunction,
including endothelial dysfunction, atherogenesis and launching/initiation of athero-
sclerotic plaque rupture have already been demonstrated by other studies. Our aim of
this study was to evaluate the slOX-1 serum levels in patients with SCF phenomenon.
Methods: A total of 40 patients with angiographically proven coronary slow ﬂow
phenomenon (23 males and 17 females, mean age 56,3313,04 years) and 43 patients
with normal coronary arteries and normal coronary ﬂow (16 males and 27 females,
mean age 55,66,51 years) were included in this cross-sectional observational study.
Coronary blood ﬂow was measured according to the TIMI (Thrombolysis In
Myocardial Infarction) frame count method for the all coronary arteries. sLOX-1
levels were measured in all study subjects from serum samples by sandwich enzyme-
linked immunosorbent assay.
Results: Serum levels of sLOX-1 were signiﬁcantly higher in the SCF group than
normal coronary artery group (1061,80422,20ng/ml vs. 500,043282,97 ng/ml,
p<0.001, respectively). Also correlation analysis showed a positive correlation
between serum sLOX-1 levels and the mean TIMI frame count (r<0.001).
Conclusıon: The results of the present study show signiﬁcantly higher sLOX-1 levels
in patients with SCF compared to control subjects. The ﬁndings point out, sLOX-1
may be contributed in the pathogenesis of coronary slow ﬂow.PP-275
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Background: Coronary artery disease (CAD) is the most common cause of death in
the world. An estimated 6% to 10% of myocardial infarction occurs in patients under
the age of 45. Atherosclerosis is the main cause. In the present study, we investigated
the risk factors and distribution of coronary artery lesions, under 45 years of age in
141 patients admitted to our hospital with ST-elevation myocardial infarction
(STEMI).
Methods: We reviewed 141 patients treated with primary angioplasty for STEMI
were aged 45 or less. The demographic information and the risk factors for the cases
were recorded, primary PCI results were analyzed. For this purpose, fasting bloodC192 JACC Voglucose, lipid panel, D-dimer, hs-CRP, homocysteine, blood pressure and body mass
index were measured.
Results: The average age of the patients was 38.34.6 years. These patients were
predominantly male (87.9%). 57% anterior, 41% inferior and 2% isolated posterior
myocardial infarction (MI) were recorded. Cigarette smoking was present in 82% of
patients. Low HDL (female <50 mg/dl, male <40 mg/dl), hypertriglyceridemia
(>150 mg/dl), high LDL (>130 mg/dl) and family history respectively 66%, 52%,
38% and 25% were common risk factors. 43% of patients were overweight (BMI >25
kg/m2) and 30% of patients were obese (BMI >30 kg/m2) (Figure 1). Ratio of the
patients with hypertension and diabetes mellitus (13% and 11%, respectively) were
lower. Blood levels of hsCRP (> 1 mg / L), homocysteine (>13.9 mmol / L), D-dimer
(>232 ng / ml) and ﬁbrinogen (>380 mg / dl) were elevated in 56%, 59%, 40% and
34% of the patients, respectively. 66% of patients have single vessel disease. The most
common vessel was the left anterior descending artery (51%) and then circumﬂex
artery involvement was detected (27%) among the patients (Figure 2).
Conclusıons: Smoking is the most important risk factor for CAD in young patients
with STEMI. In addition, atherogenic dyslipidemia and obesity are the second and
third most frequent risk factors in our study. Atherogenic dyslipidemia, obesity and
smoking effect synergistically on the development of coronary atherosclerosis espe-
cially in young patients with familial predisposition. All above-mentioned risk factors
take a role synergistically on the development of CAD, especially in young patients
with familial predisposition.PP-276
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Objectıves: Stent thrombosis is an uncommon but potentially fatal complication of
percutaneous coronary interventions (PCI). In recent years, the predictive and prog-
nostic value of the red cell distribution width (RDW), an indicator of inﬂammation,
has been shown in several cardiovascular diseases. Aim of this study was to evaluate
the predictive value of RDW on the development of stent thrombosis in patients
undergoing successful stent implantation for acute ST-elevation myocardial infarc-
tion(MI) treatment.
Methods: We included 321 patients (mean age 55.3  10.4 years, 86% male) who
had undergone successful stent implantation for acute ST-elevation MI treatment andl 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTERS
Multivariate regression analysis showing independent predictors of saphenous
vein graft occlusion.
Odds ratio 95% conﬁdence interval P value
Time after CABG surgery 0.93 0.87-0.99 0.04
MPV 0.26 0.17-0.39 <0.001
HDL cholesterol 1.04 1.01-1.08 0.012
Fibrinogen 0.27 0.16-0.48 <0.001
CABG, coronary artery bypass graft; HDL, high-density lipoprotein; MPV, mean platelet volume.
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ical, hematologic, and angiographic datas were analyzed.
Results: Patients were divided into 3 tertiles according to the RDW values (12.9 
0.4, 14.2  0.4 and 16.3  1.5 respectively). Stent thrombosis developed in 47
(40.9%) patients in the lowest tertile, 39 (37.9%) patients in the middle tertile and 60
(58.3%) patients in the highest tertile (p¼0.006). Female gender ratio was signiﬁcantly
high in the highest tertile (13 (11.3%), 8 (7.8%), 24 (23.3%), p¼0.003, respectively).
The RDW (odds ratio:1.397, 95% CI: 1.177- 1.657, p<0.001), platelet count (odds
ratio:1.008, 95% CI: 1.004-1.012, p<0.001) remained independent predictors of stent
thrombosis after multivariate logistic regression analysis. Receiver–operating char-
acteristic (ROC) curve analysis demonstrated a cut off value 13.9 for the RDW,
predicted the development of stent thrombosis with a sensitivity of 57% and speci-
ﬁcity of 52% (Area under the ROC curve: 0.59, 95% CI: 0.53 to 0.65, p¼0.007).
Conclusıon: High RDW values were found to be independently associated with the
development of stent thrombosis in patients with ST-elevation MI.
PP-277
The Pharmacoeconomic Efﬁcacy of Ivabradine and Nebivolol Treatment of
Stable Angina Pectoris in Patients with Left Ventricular Dysfunction
Rasim Kutlu1, Mehmet Erdem Memetoglu2
1Gümüs¸hane State Hospital, Department of Cardiology, Gümüs¸hane, 2Siyami Ersek
Educating and Training Hospital, Department of Cardiovascular Surgery, _Istanbul
Background: We aimed to investigate the pharmacoeconomic efﬁcacy of ivabradine
and nebivolol in treatment of stable angina pectoris patients with left ventricular
dysfunction.
Methods: This prospective study included 34 patients with a left ventricular ejection
fraction (LVEF) 40% that were followed-up by the cardiology department; 15 (44%)
patients were male, 19 (56%) were female, and mean age was 615.1 years. Patients
treated with nebivolol (17 patients, 50%) formed nebivolol group, patients who could
not tolerate nebivolol and treated with ivabradine (17 patients, 50%) formed ivabra-
dine group. The parameters recorded included heart rates, LVEF, hospitalization rates,
quality of life (QoL) based on the Seattle Angina Questionnaire (SAQ) scores, the
Duke Treadmill Score (DTS). Pharmacoeconomic analysis was performed by using
Cost Minimization Analysis (CMA), and Cost Effectiveness Analysis (CEA).
Results: After 6 months’ treatment ivabradine (mean dose 122.5 mg daily) reduced
heart rate by (1028.9) to (663.2) beat per minute (bpm), (p<0.05), and nebivolol
(mean dose 40.8 mg/day) reduced heart rate by (1059.1) to (674.3) bpm
(p<0.05). LVEF for the nebivolol group improved by (386.5) to (413.2), (p>0.05)
and for the ivabradine group (375.4) to (412.3), (p>0.05). The mean MET value
in the nebivolol group increased from (3.71.2) to (5.51.6), (p>0.05), versus from
(3.61.5) to (5.51.4), (p>0.05) in the ivabradine group. After 6 months’ treatment
CMA results showed a difference in the total cost of treatment was $ 5288.70 in favor
of nebivolol.
Conclusıons: The ﬁndings of this study suggest that nebivolol is more cost-effective
than ivabradine in the treatment of stable angina pectoris in patients with left
ventricular dysfunction.
PP-278
Association between Plasma Fibrinogen Level and Saphenous Vein Graft
Patency
Sinan Cers¸it1, Serkan Çay1, Yavuzer Koza2, Sadık Kadri Açıkgöz1, Gizem Çabuk1,
Bihter S¸entürk1, Pınar Dogan1
1Turkiye Yuksek Ihtisas Hospital, Ankara, 2Ataturk University Faculty of Medicine,
Erzurum
Background: Fibrinogen is related to pathogenesis of atherosclerosis. The inﬂam-
matory process in atherosclerosis may cause an increase in plasma ﬁbrinogen level.
Therefore, in this study we purposed to investigate whether plasma ﬁbrinogen is
associated with the patency of saphenous vein graft in patients at least 1 year after
coronary artery bypass graft (CABG) surgery.
Methods: Patients who had undergone CABG surgery at least 1 year previously with
at least one saphenous vein graft were included in the study. Patients were directed to
cardiac catheterization for stable anginal symptoms or positive stress test results.
Before coronary angiography, all patients had routine blood tests including plasma
ﬁbrinogen levels.
Results: Saphenous vein grafts were found to be patent in 199 patients and occluded
in 132 patients. Plasma ﬁbrinogen levels were signiﬁcantly different between the two
groups (2.850.49 g/L vs. 3.620.82 g/L, p<0.001, respectively). Although time
after CABG operation differs signiﬁcantly between the two groups (p¼0.004),
multiple logistic regression analysis showed that plasma ﬁbrinogen levels were found
to be signiﬁcantly associated with the patency of vein graft (OR¼0.27, 95% CI 0.16-
0.48, p<0.001) (Table). In addition, a plasma ﬁbrinogen value >3.45 g/L was
determined to predict saphenous graft vein disease with a sensitivity of 57% and
a speciﬁcity of 91% (AUC (area under the curve) ¼0.784) (Figure).
Conclusıon: Our results demonstrated that plasma ﬁbrinogen levels were higher in
patients with an occluded saphenous vein graft. To prove this relationship between
plasma ﬁbrinogen values and saphenous vein graft patency, further investigations are
needed.JACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTPP-279
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Aım: Mediterranean diet (MD) is considered a model for healthy eating. However,
prospective evidence in Turkey evaluating the relationship between MD and cardio-
vascular events is scarce. We surveyed the adherence of Turkish population to MD
and its association with cardiovascular disease (CVD).
Methods-Results: Followed-up 900 participants (52 percent women) initially free of
cardiovascular disease (CVD) during 5.1 years. The general dietary habits of study
population were detected with a food frequency quetionnaire. Data obtained from that
questionnaire were tested with Mediterranean diet score in order to ﬁnd out the
relevance to Mediterranean diet. A MD score (scale 0–8) was computed reﬂecting
high ratio of monounsaturated to saturated fat; high intake of alcohol, legumes,
cereals, vegetables, and fruits; low intakes of meat and it's products, milk and dairy
products. Scoring <5 was deﬁned as Low-MD consuming, while 5+ as High-MD
consuming. We observed 25 incident cases of CVD. Consumption of High-MD was
21% in men and 19% in women. The risk for myocardial infarction, coronary bypass,
angioplasty, and any cardiovascular disease in men increased by 1.3 (p¼0.02), 1.4
(p¼0.03), 1.5 (p¼0.01), and 1.3 (p¼0.02), respectively, for each MD score decrease.
In women, the risk for myocardial infarction and angioplasty increased by 1.3
(p¼0.02) and 1.5 (p¼0.01), respectively, for each MD score decrease. The risk for
coronary bypass, and any cardiovascular disease in women, crude odds ratios ranged
from 1.1 to 1.3 but were not statistically signiﬁcant.
Conclusıons: The current rate of MD in Turkey is fairly low. There is an inverse
association between adherence to MD and the incidence of fatal and non-fatal CVD in
initially healthy adults.ERS C193
